-
February 14, 2019 11:40 KST
- SpeeDx Develops Multiplex Test for Respiratory Viruses
- SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Adminis...
-
February 13, 2019 09:50 KST
- Clean management of Laser Gum Bleaching with Dr. Yumi Jung of MAGIC KISS Dental Clinic in Korea
- When someone mentions whitening (Bleaching), you will usually think of whitening of the teeth or face.
But ...
-
February 12, 2019 16:50 KST
- European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) ex...
-
February 08, 2019 11:20 KST
- Takeda Announces Results from First-of-Its-Kind Phase IIIb/IV Trial PROPEL - a Randomized PK-Guided Prophylaxis Study Evaluating Higher Factor VIII Levels in Hemophilia A- at EAHAD 2019
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”), the global biotechnology leader in rare ...
-
February 04, 2019 13:50 KST
- Takeda Reports Third Quarter FY2018 Results
- Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK):
Underlying Revenue +4.8% year-to-date with gr...
-
February 01, 2019 13:28 KST
- G+FLAS Life Sciences, a Korean CRISPR/Cas Genome Editing Company, Licenses DNA-Free Genome Editing Technologies
- G+FLAS Life Sciences, Inc. (G+FLAS), a CRISPR/Cas genome editing company in South Korea, announced that they l...
-
February 01, 2019 11:45 KST
- Takeda Scoops Prestigious Global Top Employers® Award for Second Year Running
- Takeda Pharmaceutical Company Limited [TOKYO: 4502 / NYSE: TAK], (“Takeda”) today announced it has become part...
-
January 31, 2019 18:25 KST
- Morinaga Milk's Probiotic Bifidobacterium infantis M-63 Alleviates Mental Stress of Flood Victims
- Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced new r...
-
January 31, 2019 18:10 KST
- Bioventus Launches DUROLANE® in Malaysia and Selects Athrotech as Exclusive Distribution Partner
- Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE, its single-injection joint-fluid...
-
January 30, 2019 13:45 KST
- Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
- Takeda Pharmaceutical Company Limited [TSE:4502 / NYSE:TAK] (“Takeda”) today announced that the pivotal Phase ...
-
January 30, 2019 11:55 KST
- Ensuring the Health and Safety of Global Aquaculture: House Wellness Foods’ Feed LP20® Boosts Commercial Nile Tilapia Production, Reduces Antibiotic Use
- In the ongoing effort to battle world hunger and expand the production of healthy livestock, House Wellness Fo...
-
January 24, 2019 14:59 KST
- ACCUNIQ to Supply Body Composition Analyzer to World Gym
- SELVAS Healthcare Inc. has signed a contract with World Gym International, LLC. to supply its body composition...
-
January 22, 2019 16:15 KST
- Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments
- Ferring Pharmaceuticals and Karolinska Institutet announced today a five-year extension of their collaboration...
-
January 22, 2019 13:50 KST
- ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.
- ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, a...
-
January 22, 2019 11:55 KST
- Metabolon Appoints Michael Rasche as President of International Business
- Metabolon, the world leader in metabolomics, today announced that Michael Rasche joined the company as Preside...
-
January 18, 2019 11:05 KST
- Terns Pharmaceuticals Announces the Appointment of Erin Quirk, M.D., as Chief Medical Officer
- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecular...
-
January 11, 2019 09:00 KST
- Korean Health Food Distribution Brand Nature Food Distributes ‘Chong Kun Dang 6-year-old Red Ginseng Gold’ Abroad
- Ewha Company said its food brand, Nature Food, will begin an international distribution of health food product...
-
January 11, 2019 08:55 KST
- R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide
- The new Code of Practice of the International Federation of Pharmaceutical Manufacturers and Associations (IFP...
-
January 10, 2019 09:40 KST
- FotoFinder Systems: Artificial Intelligence Revolutionizes Skin Cancer Detection
- “Artificial Intelligence” (AI) is currently on everyone's lips. Experts say companies need to focus on th...
-
January 10, 2019 09:10 KST
- Mobi Is Here: ResMed’s First Portable Oxygen Device Now Widely Available in the U.S.
- ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, ...
-
January 09, 2019 19:10 KST
- Takeda Completes Acquisition of Shire, Becoming a Global, Values-Based, R&D-Driven Biopharmaceutical Leader
- Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced the completion of its...
-
January 09, 2019 09:15 KST
- Cambridge Epigenetix announces programme for routine screening and detection of colorectal cancer and other common tumours
- Cambridge Epigenetix Ltd, a pioneer in the development and application of epigenetic technologies, today annou...
-
January 08, 2019 18:00 KST
- ResMed Completes $225 Million Acquisition of Propeller Health
- ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-s...
-
January 08, 2019 13:25 KST
- Factory CRO and Boston Biomedical Associates Announce Merger
- Factory-CRO Group, a leading global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs), and Bos...
-
January 07, 2019 17:10 KST
- Solasia Initiates Phase III Program for PledOx® in Japan
- Solasia Pharma K.K. (TOKYO:4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Sol...
-
January 07, 2019 10:15 KST
- GE Healthcare, Vanderbilt University Medical Center Partner for Safer, More Precise Immunotherapy Cancer Treatment
- GE Healthcare and Vanderbilt University Medical Center (VUMC) today announced a five-year partnership to enabl...
-
January 07, 2019 10:10 KST
- Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna
- Boehringer Ingelheim and Dicerna Pharmaceuticals (NASDAQ: DRNA), a leading developer of investigational RNA in...
-
January 07, 2019 10:05 KST
- Takeda Notes Court Sanction of the Scheme of Arrangement with Respect to the Acquisition of Shire plc
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) notes Shire plc’s (“Shire”) announcement ...
-
January 04, 2019 18:00 KST
- Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders
- Boehringer Ingelheim and Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) today announced two new glo...
-
January 04, 2019 17:05 KST
- Takeda Announces Multiple Cell Therapy Collaborations to Advance the Company’s Novel Immuno-Oncology Portfolio
- Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502) today announced new research collaborations in im...
-
January 04, 2019 10:15 KST
- Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies
- Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technolo...
-
December 28, 2018 15:30 KST
- 22nd Century Files Modified Risk Tobacco Product (MRTP) Application with the FDA for the Company’s Very Low Nicotine Content Cigarettes
- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reductio...
-
December 24, 2018 11:45 KST
- Henry Schein and Vets First Choice Announce New Name of the Planned New Company: Covetrus
- Henry Schein, Inc. (Nasdaq: HSIC) and Vets First Choice today announced that the new standalone public company that will result from the pla...
-
December 20, 2018 15:15 KST
- Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange
- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION...
-
December 18, 2018 18:20 KST
- Fuji Pharma Invests in Alvotech for US$50 Million
- Biopharmaceutical company Alvotech announced today that Japan-based Fuji Pharma has acquired a 4.2% stake in t...
-
December 18, 2018 14:25 KST
- Brightree Acquires Mobile Delivery Provider Apacheta to Streamline HME Delivery
- Brightree, a leading provider of cloud-based software helping out-of-hospital providers improve business perfo...
-
December 18, 2018 11:10 KST
- Celgene Corporation Announces Celgene Cancer Care Links™ Program Grant Recipients
- Celgene Corporation (NASDAQ:CELG) today announced ten programs selected for funding under its Celgene Cancer C...
-
December 17, 2018 16:00 KST
- Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) C...
-
December 17, 2018 09:25 KST
- Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer
- Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study...
-
December 13, 2018 16:10 KST
- Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners
- Takeda Pharmaceutical Company Limited, (“Takeda”) (TSE:4502) and the New York Academy of Sciences announced to...
-
December 12, 2018 10:15 KST
- AMRA Receives U.S. FDA Clearance for AMRA® Profiler, a Magnetic Resonance Diagnostic Software Application Enabling Non-Invasive Evaluation of Body Composition
- AMRA Medical (“AMRA”), the international leader in body composition analysis, announced today that it has rece...
-
December 10, 2018 10:05 KST
- Vitruvias Therapeutics Inc., Licenses Potassium Chloride ER ANDA (10 and 20 mEq) Capsules to Be Manufactured at Bora Pharmaceutical’s New Zhunan Facility in Taiwan
- Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug development company, has agre...
-
December 06, 2018 13:40 KST
- Takeda Shareholders Approve Resolutions Related to the Proposed Acquisition of Shire plc
- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION...
-
December 05, 2018 17:50 KST
- Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas
- Seattle Genetics, Inc. (Nasdaq:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) announced that data ...
-
December 05, 2018 13:45 KST
- Takeda Announces Execution of Loan Agreement in Connection with Proposed Acquisition of Shire plc
- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION...
-
December 04, 2018 17:55 KST
- ResMed to Acquire Propeller Health, a Leader in COPD and Asthma Connected Health Solutions, for $225 Million
- ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-s...
-
December 04, 2018 11:55 KST
- Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)
- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and de...
-
December 04, 2018 11:40 KST
- Takeda to Present Positive Data from TOURMALINE-MM3, First Pivotal Phase 3 Placebo Controlled Trial Evaluating Proteasome Inhibitor Treatment in Maintenance Setting
- Takeda Pharmaceutical Company Limited (TSE:4502) today announced that data from the Phase 3 randomized, TOURMA...
-
December 04, 2018 10:35 KST
- Celgene Corporation Announces Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018
- Celgene Corporation (NASDAQ:CELG) today announced initial safety data from its ongoing proof-of-concept trial ...
-
December 04, 2018 09:05 KST
- Alteogen and Lynkogen Expand Agreement to Include Additional Proprietary Fusion Proteins Targeting NASH
- Alteogen Inc. (196170.KQ) and Lynkogen Inc. today announced that they have expanded the scope of their exclusi...
-
December 03, 2018 20:00 KST
- Vitruvias Therapeutics Inc., and Sunny Pharmtech Inc., Announce the FDA Approval of Generic Aminocaproic Acid 500 mg and 1000 mg Tablets
- Sunny Pharmtech, Inc., a Taiwan-based API and finished-dose drug development company, and Vitruvius Therapeuti...
-
December 03, 2018 19:35 KST
- ACM Global Laboratories Appoints Brian Wright as President
- Rochester Regional Health (RRH), a $2.2 USD billion integrated health care delivery system with more than 17,0...
-
December 03, 2018 15:45 KST
- European Commission Approves ALUNBRIG® (brigatinib) for ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib, Advancing Treatment Paradigm in Europe
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC) granted ma...
-
December 03, 2018 14:25 KST
- Celgene Corporation Announces Results of AUGMENT Evaluating REVLIMID® In Combination with Rituximab (R2) In Patients with Relapsed/Refractory Indolent Lymphoma At ASH 2018
- Celgene Corporation (NASDAQ: CELG) today announced results of the phase 3 AUGMENT study, which showed that REV...
-
December 03, 2018 13:55 KST
- Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 MEDALIST Trial Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session
- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from the p...
-
December 03, 2018 13:05 KST
- Celgene Corporation Announces Initial Phase 1/2 Liso-cel Data in Patients with Relapsed/Refractory CLL, Including Those with High-Risk Disease, Previously Treated with Ibrutinib, at ASH 2018
- Celgene Corporation (NASDAQ: CELG) today announced initial data from the dose-escalation part of an ongoing, o...
-
December 03, 2018 11:55 KST
- Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018
- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a piv...
-
November 30, 2018 18:00 KST
- FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain
- SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus us...
-
November 28, 2018 13:05 KST
- American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 diabetes and established cardiovascular disease in new Expert Consensus Decision Pathway
- A new Expert Consensus Decision Pathway issued by the American College of Cardiology (ACC) recommends empaglif...
-
November 23, 2018 10:25 KST
- Vineti™ to Partner With Tessa Therapeutics™ to Advance and Scale Cancer Immunotherapies World-Wide
- Vineti, Inc., the leading digital “platform of record” for personalized therapies, today announced a new partn...
-
November 21, 2018 14:10 KST
- Takeda Receives Clearance from the European Commission for the Proposed Acquisition of Shire plc
- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION...
-
November 21, 2018 13:40 KST
- ResMed Elects Harjit Gill to Its Board of Directors
- ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-se...
-
November 20, 2018 13:45 KST
- Alvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in Japan
- Alvotech and Fuji Pharma (Tokyo Stock Exchange: 4554) today announce that the two companies are entering into ...
-
November 16, 2018 17:25 KST
- SpinalCyte Announces Sustained 12-Month MRI Outcomes After CybroCell™ Injection
- SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus us...
-
November 16, 2018 15:50 KST
- ResMed Completes Acquisition of MatrixCare
- ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-s...
-
November 16, 2018 10:25 KST
- Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies
- Boehringer Ingelheim and Epizyme, Inc. (Nasdaq: EPZM) today announced a new global collaboration focused on th...
-
November 13, 2018 14:30 KST
- Takeda Announces Publication of Circular and Notice of Extraordinary General Meeting of Shareholders in Relation to the Proposed Acquisition of Shire
- Further to the announcement on May 8, 2018, by Takeda Pharmaceutical Company Limited (“Takeda” or the “Company...
-
November 13, 2018 13:10 KST
- International Consensus Statement on Postoperative Anemia Management Recommends Noninvasive Hemoglobin Measurement Including Masimo SpHb®
- Masimo (NASDAQ: MASI) announced today that a new consensus statement on postoperative anemia management was pu...
-
November 06, 2018 17:20 KST
- AlgaEnergy and Yokogawa Sign Strategic Partnership & Equity Agreement to Accelerate Growth of the Microalgae Biotech Sector
- AlgaEnergy, a Spanish biotechnology company specializing in the production and commercial applications of micr...
-
November 06, 2018 13:40 KST
- ResMed to Acquire MatrixCare, Expands Out-of-Hospital SaaS Portfolio into Long-Term Care Settings
- ResMed (NYSE: RMD) (ASX: RMD) today announced it has signed a definitive agreement to acquire privately held M...
-
November 06, 2018 13:30 KST
- OptraSCAN® Unveils High-Speed, High-Throughput, High-Capacity and High-Content “Multi-Modality Digital Slide Scanner”
- OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today unveiled a new Multi-Modality Dig...
-
November 06, 2018 10:35 KST
- Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease
- Initial effectiveness results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE)...
-
November 06, 2018 09:00 KST
- Aurigene to Present Multiple Programs at the SITC 2018 in Washington D.C. and EORTC-NCI-AACR 2018 in Dublin
- Aurigene:
SITC - Nov 7-11, Washington D.C.:
(a) CA-170 - Small molecule oral antagonist of PD-L1/VISTA i...
-
November 05, 2018 10:30 KST
- Takeda to Present Data During 60th American Society of Hematology Annual Meeting on Wide Array of Treatment Needs for Blood Cancers
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will present a total of 18 company-s...
-
November 01, 2018 14:20 KST
- Galderma, Nestlé Skin Health’s Medical Solutions Business, Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis
- Galderma, Nestlé Skin Health’s medical solutions business, today announced positive results from a Phase 2b do...
